HomeLatestNifty closes beneath 24,000, Sensex falls 720 factors amid crude surge; pharma...

Nifty closes beneath 24,000, Sensex falls 720 factors amid crude surge; pharma tariff worries

Mumbai (Maharashtra) [India], July 22 (ANI): Indian fairness benchmark indices closed decrease on Wednesday as surging crude oil costs and contemporary issues over US tariffs on generic drug imports weighed on investor sentiment.

The BSE Sensex ended the session at 76,749.60, down 720.51 factors or 0.93 per cent, whereas the Nifty 50 closed at 23,996.25, falling 191.45 factors or 0.79 per cent.

According to market consultants, issues over rising geopolitical tensions, increased crude oil costs, strain on the rupee and uncertainty over proposed US tariffs on pharmaceutical exports led to broad-based promoting in the course of the session.

Vinod Nair, Head of Research at Geojit Investments Limited, mentioned, ‘Indian equities ended decrease as the continuing US-Iran standoff and Houthi-led disruptions to key world transport routes heightened issues over potential oil provide disruptions, driving crude costs increased and weakening the rupee.’

He added that the risk-off sentiment because of renewed issues over home inflation overshadowed better-than-expected enterprise updates and inspiring first-quarter earnings. Rate-sensitive sectors corresponding to realty, banking and client durables led the decline, whereas pharmaceutical shares got here underneath strain amid renewed uncertainty over proposed US tariff measures on pharmaceutical exports.

Nair mentioned that regardless of the cautious market surroundings, FMCG and auto shares emerged as relative outperformers, supported by sturdy quarterly earnings from sector leaders.

Market sentiment was additionally impacted after US President Donald Trump introduced plans to impose tariffs of as much as 200 per cent on generic drug imports from 2028.

Under the announcement, generic medication imported into the US will proceed to draw zero per cent tariffs for 2 years from August 1, 2026, after which the tariff will rise to 100 per cent for one 12 months and 200 per cent thereafter. The announcement put strain on Indian pharmaceutical shares in the course of the buying and selling session.

Among the sectoral indices on the NSE, Nifty Auto gained 0.20 per cent and Nifty FMCG rose 0.74 per cent. All different sectoral indices closed within the crimson. Nifty IT declined 1.56 per cent, Nifty Media misplaced 2.67 per cent, Nifty Metal fell 0.57 per cent, Nifty Pharma dropped 1.31 per cent, whereas Nifty PSU Bank declined 1.89 per cent.

At the time of reporting, Brent crude oil costs had surged greater than 4 per cent to USD 95.30 per barrel. The Indian rupee was buying and selling at Rs 96.54 per US dollar.

Riyank Arora, Associate Vice President – HNI & Derivatives at Hedged.in, mentioned at present’s decline was pushed by broad-based revenue reserving and cautious market sentiment. He mentioned the medium-term development stays constructive so long as key assist ranges maintain, and suggested merchants to stay selective, keep away from aggressive lengthy positions and think about a buy-on-dips method close to sturdy assist zones with strict threat administration.

In different Asian markets, Japan’s Nikkei 225 index declined 0.10 per cent, Hong Kong’s Hang Seng index fell 1.04 per cent, whereas Singapore’s Straits Times gained 1.24 per cent and South Korea’s KOSPI superior 0.73 per cent. (ANI)

Source

Latest